(Q50988343)

English

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups.

scientific article published in November 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Latanoprost, a prostaglandin analog, for glaucoma therapy. Efficacy and safety after 1 year of treatment in 198 patients. Latanoprost Study Groups. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

1 reference

based on heuristic

inferred from title

author name string

Camras CB

1

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Alm A

2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Watson P

3

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Stjernschantz J

4

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

publication date

1 November 1996

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

103

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

11

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

1916-1924

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical Epinephrine in Glaucoma Suspects

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial of timolol and epinephrine in the treatment of primary open-angle glaucoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Ocular Pigmentation on Hypotensive Response to Pilocarpine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular Pigmentation and Pressure and Outflow Responses to Pilocarpine and Epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930407-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(96)30407-7

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/8942890

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50988343&oldid=1561846500"